Furthermore, activation of FXR has been shown to restrict the expression of inflammatory cytokines such as IL-1β and IL-6, and chemokines such as CCL2 in mouse colitis models and human CD14+ monocytes and DCs in vitro (107). This evidence concerns the gene IL6 and colitis.